Commerzbank Aktiengesellschaft’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-335,203
| Closed | -$3.56K | – | 1012 |
|
|
2016
Q2 | $3.56K | Hold |
335,203
| – | – | 0.02% | 285 |
|
|
2016
Q1 | $6.33M | Hold |
335,203
| – | – | 0.05% | 191 |
|
|
2015
Q4 | $8.92M | Buy |
335,203
+103
| +0% | +$2.74K | 0.07% | 169 |
|
|
2015
Q3 | $15.3M | Hold |
335,100
| – | – | 0.11% | 111 |
|
|
2015
Q2 | $10.8M | Hold |
335,100
| – | – | 0.06% | 183 |
|
|
2015
Q1 | $10.7M | Hold |
335,100
| – | – | 0.06% | 187 |
|
|
2014
Q4 | $12.7M | Hold |
335,100
| – | – | 0.08% | 177 |
|
|
2014
Q3 | $8.85M | Buy |
335,100
+60,100
| +22% | +$1.59M | 0.04% | 306 |
|
|
2014
Q2 | $8.14M | Hold |
275,000
| – | – | 0.04% | 282 |
|
|
2014
Q1 | $10.2M | Buy |
275,000
+125,000
| +83% | +$4.63M | 0.04% | 223 |
|
|
2013
Q4 | $5.28M | Buy |
150,000
+100,000
| +200% | +$3.52M | 0.03% | 377 |
|
|
2013
Q3 | $2.65M | Sell |
50,000
-1,070
| -2% | -$56.7K | 0.01% | 557 |
|
|
2013
Q2 | $2.73M | Buy |
+51,070
| New | +$2.73M | 0.01% | 588 |
|